Novo Nordisk is a focused healthcare company and the world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as coagulation disorders, growth disorders and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
With headquarters in Denmark, Novo Nordisk employs approximately 14,000 people in 68 countries and markets its products in 179 countries. For further company information visit www.novonordisk.com
With headquarters in Denmark, Novo Nordisk employs approximately 14,000 people in 68 countries and markets its products in 179 countries. For further company information visit www.novonordisk.com
For further information please contact:
Media:
Outside North America
Karsten Madsen
Tel: (direct): (+45) 4442 4137
Outside North America
Karsten Madsen
Tel: (direct): (+45) 4442 4137
In North America
Susan Jackson
Tel: (+1) 212-867-0123
Susan Jackson
Tel: (+1) 212-867-0123
Investors:
Outside North America
Peter Haahr
Tel: (direct): (+45) 4442 1207
Outside North America
Peter Haahr
Tel: (direct): (+45) 4442 1207
Palle Holm Olesen
Tel: (direct): (+45) 4442 6175
Tel: (direct): (+45) 4442 6175
In North America:
Rasmus Holm-Jørgensen
Phone (direct): (+1) 212-878-9607
Rasmus Holm-Jørgensen
Phone (direct): (+1) 212-878-9607
Stock Exchange Announcement No 7 / 2001